Discover the power of "triple-threat stocks" today!

Legendary investor, Tim Melvin, unearths overlooked "triple-threat stocks" in his Yield Report. Want a short at handsome opportunities in both a bear and bull market? See if you qualify for The Yield Report. Read the qualifications right here right now.

Analyst Stock Ratings Initiations

date
▲▼
ticker
▲▼
Buy Now
Company
▲▼
Current price
▲▼
Upside/Downside
▲▼
Analyst Firm
▲▼
Analyst & % Accurate
▲▼
Price Target Change
▲▼
Rating Change
▲▼
Previous / Current Rating
▲▼
Get Alert
04/30/2024CTNMBuy Now
Contineum Therapeutics
$16.0281.02%Stifel
Paul Matteis49%
 → $29Initiates → BuyGet Alert
04/30/2024LXRXBuy Now
Lexicon Pharmaceuticals
$1.62208.64%Leerink Partners— → $5Initiates → OutperformGet Alert
04/30/2024IMNMBuy Now
Immunome
$14.3966.78%JP Morgan
Brian Cheng41%
 → $24Initiates → OverweightGet Alert
04/30/2024MNSOBuy Now
MINISO Group Holding
$23.0030.43%JP Morgan
Kevin Yin1%
 → $30Initiates → OverweightGet Alert
04/30/2024OVIDBuy Now
Ovid Therapeutics
$3.39165.49%B. Riley Securities
Kalpit Patel47%
 → $9Initiates → BuyGet Alert
04/30/2024PVHBuy Now
PVH
$112.901.86%Jefferies
Ashley Helgans22%
 → $115Initiates → HoldGet Alert
04/30/2024RLBuy Now
Ralph Lauren
$167.0316.75%Jefferies
Ashley Helgans22%
 → $195Initiates → BuyGet Alert
04/30/2024DTILBuy Now
Precision BioSciences
$9.9590.95%Guggenheim
Debjit Chattopadhyay56%
 → $19Initiates → BuyGet Alert
04/30/2024TSATBuy Now
Telesat
$7.1426.05%Deutsche Bank
Edison Yu23%
 → $9Initiates → HoldGet Alert
04/30/2024AVBPBuy Now
ArriVent BioPharma
$16.5551.06%HC Wainwright & Co.
Robert Burns45%
 → $25Initiates → BuyGet Alert
04/30/2024ADVMBuy Now
Adverum Biotechnologies
$10.01199.7%HC Wainwright & Co.
Matthew Caufield37%
 → $30Initiates → BuyGet Alert
04/30/2024CTNMBuy Now
Contineum Therapeutics
$16.0287.27%RBC Capital
Brian Abrahams65%
 → $30Initiates → OutperformGet Alert
04/30/2024EEBuy Now
Excelerate Energy
$17.1522.45%Stephens & Co.
Mike Scialla73%
 → $21Initiates → OverweightGet Alert
04/30/2024DYNBuy Now
Dyne Therapeutics
$26.0153.79%Morgan Stanley
Michael Ulz71%
 → $40Initiates → OverweightGet Alert
04/30/2024CTNMBuy Now
Contineum Therapeutics
$16.0256.05%Morgan Stanley
Jeffrey Hung58%
 → $25Initiates → OverweightGet Alert
04/29/2024NYAXBuy Now
Nayax
$26.638.9%UBS
Nik Cremo36%
 → $29Initiates → NeutralGet Alert
04/29/2024THRBuy Now
Thermon Group Holdings
$32.4329.51%CJS Securities— → $42Initiates → Market OutperformGet Alert
04/29/2024RELLBuy Now
Richardson Electronics
$10.8020.37%Northland Capital Markets— → $13Initiates → OutperformGet Alert
04/29/2024SKYXBuy Now
SKYX Platforms
$1.03385.44%Noble Capital Markets
Patrick McCann59%
 → $5Initiates → OutperformGet Alert

Recent Analyst Stock Rating Initiation News

Leerink Partners Initiates Coverage On Lexicon Pharmaceuticals with Outperform Rating, Announces Price Target of $5
Leerink Partners initiates coverage on Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Outperform rating and announces Price Target of $5.
JP Morgan Initiates Coverage On Immunome with Overweight Rating, Announces Price Target of $24
JP Morgan analyst Brian Cheng initiates coverage on Immunome (NASDAQ:IMNM) with a Overweight rating and announces Price Target of $24.
JP Morgan Initiates Coverage On MINISO Group Holding with Overweight Rating, Announces Price Target of $30
JP Morgan analyst Kevin Yin initiates coverage on MINISO Group Holding (NYSE:MNSO) with a Overweight rating and announces Price Target of $30.
B. Riley Securities Initiates Coverage On Ovid Therapeutics with Buy Rating, Announces Price Target of $9
B. Riley Securities analyst Kalpit Patel initiates coverage on Ovid Therapeutics (NASDAQ:OVID) with a Buy rating and announces Price Target of $9.
Jefferies Initiates Coverage On PVH with Hold Rating, Announces Price Target of $115
Jefferies analyst Ashley Helgans initiates coverage on PVH (NYSE:PVH) with a Hold rating and announces Price Target of $115.
Jefferies Initiates Coverage On Ralph Lauren with Buy Rating, Announces Price Target of $195
Jefferies analyst Ashley Helgans initiates coverage on Ralph Lauren (NYSE:RL) with a Buy rating and announces Price Target of $195.
Guggenheim Initiates Coverage On Precision BioSciences with Buy Rating, Announces Price Target of $19
Guggenheim analyst Debjit Chattopadhyay initiates coverage on Precision BioSciences (NASDAQ:DTIL) with a Buy rating and announces Price Target of $19.
Deutsche Bank Initiates Coverage On Telesat with Hold Rating, Announces Price Target of $9
Deutsche Bank analyst Edison Yu initiates coverage on Telesat (NASDAQ:TSAT) with a Hold rating and announces Price Target of $9.
HC Wainwright & Co. Initiates Coverage On ArriVent BioPharma with Buy Rating, Announces Price Target of $25
HC Wainwright & Co. analyst Robert Burns initiates coverage on ArriVent BioPharma (NASDAQ:AVBP) with a Buy rating and announces Price Target of $25.
HC Wainwright & Co. Initiates Coverage On Adverum Biotechnologies with Buy Rating, Announces Price Target of $30
HC Wainwright & Co. analyst Matthew Caufield initiates coverage on Adverum Biotechnologies (NASDAQ:ADVM) with a Buy rating and announces Price Target of $30.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free